VIVEVE MED INC - COM NEW (VIVE)

CUSIP: 92852W204

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / COM NEW
Total 13F shares
17,580,798
Share change
-1,815,164
Total reported value
$47,102,309
Put/Call ratio
169%
Price per share
$2.68
Number of holders
36
Value change
-$4,942,083
Number of buys
16
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 92852W204?
CUSIP 92852W204 identifies VIVE - VIVEVE MED INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIVEVE MED INC - COM NEW (VIVE) as of Q3 2018

As of 30 Sep 2018, VIVEVE MED INC - COM NEW (VIVE) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,580,798 shares. The largest 10 holders included Nantahala Capital Management, LLC, Stonepine Capital Management, LLC, RTW INVESTMENTS, LP, HighTower Advisors, LLC, Vanguard Group Inc, Polar Capital LLP, BlackRock Inc., GRANAHAN INVESTMENT MANAGEMENT INC/MA, MEITAV DASH INVESTMENTS LTD, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 36 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.